CAMPBELL, Calif.--(BUSINESS WIRE)--Imperative Care, Inc. today announced that it has received U.S. Food and Drug Administration (FDA) 510(k) clearance of the company’s Zoom System, making it the ...
Imperative Care has received a green light from the FDA for its large-bore catheter to help remove stroke-causing blood clots from within the brain. The new 510(k) clearance expands the portfolio ...
The US Food and Drug Administration (FDA) has granted 510(k) clearance for Imperative Care’s Zoom System, marking an advancement in stroke thrombectomy procedures. The clearance marks it as the ...
Pulse, which named a new CEO last month, is pitching its pulsed field ablation technology as a way to shorten procedure times ...
Pulse Biosciences (Nasaq:PLSE) announced today that it appointed Jon Skinner as CFO, effective Feb. 3, 2025.
Given the unprecedented potential for sweeping immigration enforcement actions that may include health care settings, health ...
088-in. catheters to get close to the clot. [Image courtesy of Imperative Care] Imperative Care announced today that it has secured FDA 510(k) clearance for its Zoom comprehensive stroke ...
The med tech patent wars conscripted another two companies via a patent infringement lawsuit between Inari Medical Inc. and Imperative Care Inc. — a struggle that is playing out in a California ...
Earth Commission Report1 provides major new insights into the potential for the transgression of Earth-system boundaries ...